中药纳米制剂在肿瘤免疫靶向治疗中的研究进展  被引量:3

Research progress of traditional Chinese medicine nano-preparations in tumor immunotargeted therapy

在线阅读下载全文

作  者:李嘉翔 李汾[2] LI Jiaxiang;LI Fen(Shaanxi University of Chinese Medicine,Shaanxi Xianyang 712046,China;Xi'an Medical University,Shaanxi Xi'an 710021,China)

机构地区:[1]陕西中医药大学,陕西咸阳712046 [2]西安医学院,陕西西安710021

出  处:《现代肿瘤医学》2023年第18期3512-3519,共8页Journal of Modern Oncology

摘  要:恶性肿瘤已成为严重威胁人民生命健康的一类疾病。随着肿瘤免疫靶向治疗的应用,中药已显示出巨大的优势。抗肿瘤中药纳米制剂,在改善药物生物利用度,提高药物对肿瘤组织的靶向性,降低药物毒性方面的优势越发明显。中药纳米制剂用于抗肿瘤免疫靶向治疗虽然还在起步阶段,但相信不久的将来会更加成熟。本文就中药纳米制剂在肿瘤免疫靶向治疗方面的进展进行综述。Malignant tumors have become a serious threat to people's lives and health.With the application of tumor immunotargeted therapy,traditional Chinese medicine has shown tremendous advantages.The advantages of anti-tumor traditional Chinese medicine nano-preparations in improving drug bioavailability,enhancing drug targeting to tumor tissue,and reducing drug toxicity are becoming increasingly evident.Although the application of traditional Chinese medicine nano-preparations in anti-tumor immunotargeted therapy is still in its infancy,it is believed that it will be more mature in the near future.This paper reviews the progress of traditional Chinese medicine nano-preparations in tumor immunotargeted therapy.

关 键 词:中药 纳米制剂 抗肿瘤 免疫 靶向 

分 类 号:R730.5[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象